Annual Short Term Debt
$5.38 M
+$2.66 M+97.36%
31 December 2023
Summary:
Adaptimmune Therapeutics annual short term debt is currently $5.38 million, with the most recent change of +$2.66 million (+97.36%) on 31 December 2023. During the last 3 years, it has risen by +$2.61 million (+94.16%). ADAP annual short term debt is now at all-time high.ADAP Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Short Term Debt
$4.17 M
-$1.12 M-21.12%
30 September 2024
Summary:
Adaptimmune Therapeutics quarterly short term debt is currently $4.17 million, with the most recent change of -$1.12 million (-21.12%) on 30 September 2024. Over the past year, it has dropped by -$906.00 thousand (-17.83%). ADAP quarterly short term debt is now -22.46% below its all-time high of $5.38 million, reached on 31 December 2023.ADAP Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ADAP Short Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +97.4% | -17.8% |
| 3 y3 years | +94.2% | +84.2% |
| 5 y5 years | +100.0% | +78.7% |
ADAP Short Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +132.1% | -22.5% | +84.2% |
| 5 y | 5 years | at high | -22.5% | +84.2% | |
| alltime | all time | at high | -22.5% |
Adaptimmune Therapeutics Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $4.17 M(-21.1%) |
| June 2024 | - | $5.29 M(+0.8%) |
| Mar 2024 | - | $5.25 M(-2.5%) |
| Dec 2023 | $5.38 M(+97.4%) | $5.38 M(+6.0%) |
| Sept 2023 | - | $5.08 M(+6.9%) |
| June 2023 | - | $4.75 M(+67.2%) |
| Mar 2023 | - | $2.84 M(+4.2%) |
| Dec 2022 | $2.73 M(+17.6%) | $2.73 M(+10.3%) |
| Sept 2022 | - | $2.47 M(-3.2%) |
| June 2022 | - | $2.56 M(-6.5%) |
| Mar 2022 | - | $2.73 M(+17.9%) |
| Dec 2021 | $2.32 M | $2.32 M(+2.3%) |
| Sept 2021 | - | $2.27 M(-22.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2021 | - | $2.92 M(+2.7%) |
| Mar 2021 | - | $2.85 M(+2.6%) |
| Dec 2020 | $2.77 M(+11.2%) | $2.77 M(+5.9%) |
| Sept 2020 | - | $2.62 M(+5.1%) |
| June 2020 | - | $2.49 M(-3.7%) |
| Mar 2020 | - | $2.59 M(+3.9%) |
| Dec 2019 | $2.49 M(>+9900.0%) | $2.49 M(+6.7%) |
| Sept 2019 | - | $2.34 M(-0.0%) |
| June 2019 | - | $2.34 M(+5.5%) |
| Mar 2019 | - | $2.22 M(>+9900.0%) |
| Dec 2018 | $0.00(-100.0%) | $0.00 |
| June 2013 | $1.54 M(>+9900.0%) | - |
| June 2012 | $0.00 | - |
FAQ
- What is Adaptimmune Therapeutics annual short term debt?
- What is the all time high annual short term debt for Adaptimmune Therapeutics?
- What is Adaptimmune Therapeutics annual short term debt year-on-year change?
- What is Adaptimmune Therapeutics quarterly short term debt?
- What is the all time high quarterly short term debt for Adaptimmune Therapeutics?
- What is Adaptimmune Therapeutics quarterly short term debt year-on-year change?
What is Adaptimmune Therapeutics annual short term debt?
The current annual short term debt of ADAP is $5.38 M
What is the all time high annual short term debt for Adaptimmune Therapeutics?
Adaptimmune Therapeutics all-time high annual short term debt is $5.38 M
What is Adaptimmune Therapeutics annual short term debt year-on-year change?
Over the past year, ADAP annual short term debt has changed by +$2.66 M (+97.36%)
What is Adaptimmune Therapeutics quarterly short term debt?
The current quarterly short term debt of ADAP is $4.17 M
What is the all time high quarterly short term debt for Adaptimmune Therapeutics?
Adaptimmune Therapeutics all-time high quarterly short term debt is $5.38 M
What is Adaptimmune Therapeutics quarterly short term debt year-on-year change?
Over the past year, ADAP quarterly short term debt has changed by -$906.00 K (-17.83%)